Analyst Recommendations

Jefferies analyst issues BUY recommendation for VEEV on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.VEEV was trading at $222.01 at issue of the analyst...

March 4, 2024   VEEV -0.81%

BTIG analyst issues BUY recommendation for MGNX on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.MGNX was trading at $19.06 at issue of the analyst...

March 4, 2024   MGNX -4.05%

Cowen & Co. analyst issues OUTPERFORM recommendation for MTZ on March 4, 2024 07:56AM ET. The previous analyst recommendation was Outperform.MTZ was trading at $84.85 at issue of...

March 4, 2024   MTZ -0.40%

Wells Fargo analyst issues OVERWEIGHT recommendation for DLTR on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.DLTR was trading at $148.44 at issue of the...

March 4, 2024   DLTR 0.18%

Cowen & Co. analyst issues NEUTRAL recommendation for QURE on March 4, 2024 07:56AM ET. The previous analyst recommendation was Neutral.QURE was trading at $5.59 at issue of...

March 4, 2024   QURE -1.23%

Wedbush analyst issues BUY recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM -1.53%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM -1.53%

Wedbush analyst issues UNDERPERFORM recommendation for AMD on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.AMD was trading at $202.64 at issue of the analyst...

March 4, 2024   AMD 0.69%

Wells Fargo analyst issues BUY recommendation for AMD on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.AMD was trading at $202.64 at issue of the...

March 4, 2024   AMD 0.69%

UBS analyst issues UNDERPERFORM recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.COST was trading at $749.44 at issue of the analyst...

March 4, 2024   COST 0.04%